市場調査レポート

商品コード

1193142

電子喉頭（エレクトロラリンクス）市場：タイプ別（内蔵バッテリー、外部バッテリー）、用途別（喉頭がん、スピーチリハビリ）、エンドユーザー別（病院、外来手術センター、その他）：世界の機会分析および産業予測、2021-2031年

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年10月01日 | 発行: Allied Market Research

| ページ情報: 英文 190 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

電子喉頭の世界市場は2021年に4億950万米ドル、2031年には7億300万米ドルに達すると予測され、2022年から2031年にかけてCAGR5.5%で成長しています。

電子喉頭（エレクトロラリンクス）は、人が話すことができるように音を発生させるバッテリー駆動の機器です。様々なメーカーやモデルがありますが、一般的には小型の電気カミソリ程度の大きさです。人が話したいときに、この小さな電池式の小道具を首のあごの下に装着します。ボタンを押すと、振動が皮膚からのどに伝わります。その音を口、舌、唇、歯で表現し、言葉にします。

人工喉頭は、声を失った人が、音声の周波数パラメータを調整・保存することで、よりよい発声ができるようにする装置です。音声復元装置は、喉頭と呼ばれる声帯全体を永久に切除し、気管と食道を分離する喉頭摘出術の後に最も活用されます。

市場の成長を促進する重要な要因は、喉頭がんの有病率の上昇とアルコールとタバコの消費の急増は、electrolarynx市場を駆動する主要な要因であるされています。例えば、米国がん協会が発表したレポートによると、2022年の米国における喉頭がんについては、新たに約12,470人（男性9,820人、女性2,650人）が喉頭がんで死亡したと推定されています（3,070男性、750女性）。さらに、ヒトパピローマウイルス（HPV）によって引き起こされる呼吸器乳頭腫の症例が増加していることは、通常は良性（がんではない）であることを示しています。これらの腫瘍は声帯の損傷や気道の問題につながる可能性があり、電子喉頭装置の需要を増大させ、市場の成長を促進しています。さらに、これらの医療機器の高い採用率と、革新的で技術的に高度な電子喉頭装置の発売のために多くの主要なプレーヤーによる研究開発への継続的な投資は、市場の成長を促進すると予想されています。

しかし、電子喉頭装置のコストが高いことが市場の成長を阻害しています。逆に、下咽頭がんの症例数の増加、新興国のヘルスケア市場の台頭、基本的なヘルスケアへのアクセスがない低所得国、喉頭がんのリスクの増加は、予測期間中に市場成長のための有利な機会を提供すると期待されます。

概要
- 市場規模・予測
内蔵型バッテリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
外付けバッテリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第5章電子喉頭（エレクトロラリンクス）市場：アプリケーション別

概要
- 市場規模・予測
喉頭がん
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
スピーチリハビリテーション
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第6章電子喉頭（エレクトロラリンクス）市場：エンドユーザー別

概要
- 市場規模・予測
病院
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
外来手術センター
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第7章電子喉頭（エレクトロラリンクス）市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：タイプ別
- 北米市場規模・予測：アプリケーション別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：タイプ別
- 欧州市場規模・予測：アプリケーション別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：タイプ別
- アジア太平洋地域の市場規模・予測：アプリケーション別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：タイプ別
- LAMEAの市場規模・予測：アプリケーション別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - その他のLAMEA地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

Ultravoice Limited
Inhealth Technologies
Griffin Labs
Servona GmbH
Labex Trade
AMPLICORD DI GABRIELLA SALVATORE
Romet Limted
Nu-Vois, LLC
Andreas Fahl Medizintechnik-Vertrieb GmbH
Atos Medical AB

図表

LIST OF TABLES

TABLE 1. GLOBAL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 12. ELECTROLARYNX MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. ELECTROLARYNX MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 14. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. ELECTROLARYNX MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. ELECTROLARYNX MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. ELECTROLARYNX MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. GERMANY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. FRANCE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. UK ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. UK ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. ITALY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. ITALY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SPAIN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. SPAIN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. REST OF EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. REST OF EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 58. JAPAN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. JAPAN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. CHINA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. CHINA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. AUSTRALIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. AUSTRALIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. INDIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. INDIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. SOUTH KOREA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. SOUTH KOREA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 76. LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. BRAZIL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. BRAZIL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SAUDI ARABIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SAUDI ARABIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH AFRICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH AFRICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 92.ULTRAVOICE LIMITED: COMPANY SNAPSHOT
TABLE 93.ULTRAVOICE LIMITED: OPERATING SEGMENTS
TABLE 94.ULTRAVOICE LIMITED: PRODUCT PORTFOLIO
TABLE 95.ULTRAVOICE LIMITED: NET SALES
TABLE 96.ULTRAVOICE LIMITED: KEY STRATERGIES
TABLE 97.INHEALTH TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 98.INHEALTH TECHNOLOGIES: OPERATING SEGMENTS
TABLE 99.INHEALTH TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 100.INHEALTH TECHNOLOGIES: NET SALES
TABLE 101.INHEALTH TECHNOLOGIES: KEY STRATERGIES
TABLE 102.GRIFFIN LABS: COMPANY SNAPSHOT
TABLE 103.GRIFFIN LABS: OPERATING SEGMENTS
TABLE 104.GRIFFIN LABS: PRODUCT PORTFOLIO
TABLE 105.GRIFFIN LABS: NET SALES
TABLE 106.GRIFFIN LABS: KEY STRATERGIES
TABLE 107.SERVONA GMBH: COMPANY SNAPSHOT
TABLE 108.SERVONA GMBH: OPERATING SEGMENTS
TABLE 109.SERVONA GMBH: PRODUCT PORTFOLIO
TABLE 110.SERVONA GMBH: NET SALES
TABLE 111.SERVONA GMBH: KEY STRATERGIES
TABLE 112.LABEX TRADE: COMPANY SNAPSHOT
TABLE 113.LABEX TRADE: OPERATING SEGMENTS
TABLE 114.LABEX TRADE: PRODUCT PORTFOLIO
TABLE 115.LABEX TRADE: NET SALES
TABLE 116.LABEX TRADE: KEY STRATERGIES
TABLE 117.AMPLICORD DI GABRIELLA SALVATORE: COMPANY SNAPSHOT
TABLE 118.AMPLICORD DI GABRIELLA SALVATORE: OPERATING SEGMENTS
TABLE 119.AMPLICORD DI GABRIELLA SALVATORE: PRODUCT PORTFOLIO
TABLE 120.AMPLICORD DI GABRIELLA SALVATORE: NET SALES
TABLE 121.AMPLICORD DI GABRIELLA SALVATORE: KEY STRATERGIES
TABLE 122.ROMET LIMTED: COMPANY SNAPSHOT
TABLE 123.ROMET LIMTED: OPERATING SEGMENTS
TABLE 124.ROMET LIMTED: PRODUCT PORTFOLIO
TABLE 125.ROMET LIMTED: NET SALES
TABLE 126.ROMET LIMTED: KEY STRATERGIES
TABLE 127.NU-VOIS, LLC: COMPANY SNAPSHOT
TABLE 128.NU-VOIS, LLC: OPERATING SEGMENTS
TABLE 129.NU-VOIS, LLC: PRODUCT PORTFOLIO
TABLE 130.NU-VOIS, LLC: NET SALES
TABLE 131.NU-VOIS, LLC: KEY STRATERGIES
TABLE 132.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: COMPANY SNAPSHOT
TABLE 133.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: OPERATING SEGMENTS
TABLE 134.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: PRODUCT PORTFOLIO
TABLE 135.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: NET SALES
TABLE 136.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: KEY STRATERGIES
TABLE 137.ATOS MEDICAL AB: COMPANY SNAPSHOT
TABLE 138.ATOS MEDICAL AB: OPERATING SEGMENTS
TABLE 139.ATOS MEDICAL AB: PRODUCT PORTFOLIO
TABLE 140.ATOS MEDICAL AB: NET SALES
TABLE 141.ATOS MEDICAL AB: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.ELECTROLARYNX MARKET SEGMENTATION
FIGURE 2.ELECTROLARYNX MARKET,2021-2031
FIGURE 3.ELECTROLARYNX MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.ELECTROLARYNX MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.ELECTROLARYNX MARKET,BY TYPE,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BUILT-IN BATTERY ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EXTERNAL BATTERY ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 15.ELECTROLARYNX MARKET,BY APPLICATION,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LARYNGEAL CANCER ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPEECH REHABILITATION ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 18.ELECTROLARYNX MARKET,BY END USER,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROLARYNX MARKET,2021-2031(%)
FIGURE 22.ELECTROLARYNX MARKET BY REGION,2021
FIGURE 23.U.S. ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 24.CANADA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 25.MEXICO ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 26.GERMANY ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 27.FRANCE ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 28.UK ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 29.ITALY ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 30.SPAIN ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 31.REST OF EUROPE ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 32.JAPAN ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 33.CHINA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 34.AUSTRALIA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 35.INDIA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 36.SOUTH KOREA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 37.REST OF ASIA-PACIFIC ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 38.BRAZIL ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 39.SAUDI ARABIA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 40.SOUTH AFRICA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 41.REST OF LAMEA ELECTROLARYNX MARKET,2021-2031($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.ULTRAVOICE LIMITED.: NET SALES ($MILLION)
FIGURE 49.INHEALTH TECHNOLOGIES.: NET SALES ($MILLION)
FIGURE 50.GRIFFIN LABS.: NET SALES ($MILLION)
FIGURE 51.SERVONA GMBH.: NET SALES ($MILLION)
FIGURE 52.LABEX TRADE.: NET SALES ($MILLION)
FIGURE 53.AMPLICORD DI GABRIELLA SALVATORE.: NET SALES ($MILLION)
FIGURE 54.ROMET LIMTED.: NET SALES ($MILLION)
FIGURE 55.NU-VOIS, LLC.: NET SALES ($MILLION)
FIGURE 56.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH.: NET SALES ($MILLION)
FIGURE 57.ATOS MEDICAL AB.: NET SALES ($MILLION)

Product Code: A15637

The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.

The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.

The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.

However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period.

The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Built-in Battery
External Battery

By Application

Laryngeal Cancer
Speech Rehabilitation

By End user

Hospitals
Ambulatory Surgical Centers
others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Ultravoice Limited
- Inhealth Technologies
- Griffin Labs
- Servona GmbH
- Labex Trade
- AMPLICORD DI GABRIELLA SALVATORE
- Romet Limted
- Nu-Vois, LLC
- Andreas Fahl Medizintechnik - Vertrieb GmbH
- Atos Medical AB

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Built-in Battery
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3 External Battery
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Laryngeal Cancer
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3 Speech Rehabilitation
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
6.4 others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End user
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Key market trends, growth factors and opportunities
  - 7.2.5.1.2 Market size and forecast, by Type
  - 7.2.5.1.3 Market size and forecast, by Application
  - 7.2.5.1.4 Market size and forecast, by End user
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Key market trends, growth factors and opportunities
  - 7.2.5.2.2 Market size and forecast, by Type
  - 7.2.5.2.3 Market size and forecast, by Application
  - 7.2.5.2.4 Market size and forecast, by End user
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Key market trends, growth factors and opportunities
  - 7.2.5.3.2 Market size and forecast, by Type
  - 7.2.5.3.3 Market size and forecast, by Application
  - 7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End user
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Key market trends, growth factors and opportunities
  - 7.3.5.1.2 Market size and forecast, by Type
  - 7.3.5.1.3 Market size and forecast, by Application
  - 7.3.5.1.4 Market size and forecast, by End user
  - 7.3.5.2 France
  - 7.3.5.2.1 Key market trends, growth factors and opportunities
  - 7.3.5.2.2 Market size and forecast, by Type
  - 7.3.5.2.3 Market size and forecast, by Application
  - 7.3.5.2.4 Market size and forecast, by End user
  - 7.3.5.3 UK
  - 7.3.5.3.1 Key market trends, growth factors and opportunities
  - 7.3.5.3.2 Market size and forecast, by Type
  - 7.3.5.3.3 Market size and forecast, by Application
  - 7.3.5.3.4 Market size and forecast, by End user
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Key market trends, growth factors and opportunities
  - 7.3.5.4.2 Market size and forecast, by Type
  - 7.3.5.4.3 Market size and forecast, by Application
  - 7.3.5.4.4 Market size and forecast, by End user
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Key market trends, growth factors and opportunities
  - 7.3.5.5.2 Market size and forecast, by Type
  - 7.3.5.5.3 Market size and forecast, by Application
  - 7.3.5.5.4 Market size and forecast, by End user
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Key market trends, growth factors and opportunities
  - 7.3.5.6.2 Market size and forecast, by Type
  - 7.3.5.6.3 Market size and forecast, by Application
  - 7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End user
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Key market trends, growth factors and opportunities
  - 7.4.5.1.2 Market size and forecast, by Type
  - 7.4.5.1.3 Market size and forecast, by Application
  - 7.4.5.1.4 Market size and forecast, by End user
  - 7.4.5.2 China
  - 7.4.5.2.1 Key market trends, growth factors and opportunities
  - 7.4.5.2.2 Market size and forecast, by Type
  - 7.4.5.2.3 Market size and forecast, by Application
  - 7.4.5.2.4 Market size and forecast, by End user
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Key market trends, growth factors and opportunities
  - 7.4.5.3.2 Market size and forecast, by Type
  - 7.4.5.3.3 Market size and forecast, by Application
  - 7.4.5.3.4 Market size and forecast, by End user
  - 7.4.5.4 India
  - 7.4.5.4.1 Key market trends, growth factors and opportunities
  - 7.4.5.4.2 Market size and forecast, by Type
  - 7.4.5.4.3 Market size and forecast, by Application
  - 7.4.5.4.4 Market size and forecast, by End user
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Key market trends, growth factors and opportunities
  - 7.4.5.5.2 Market size and forecast, by Type
  - 7.4.5.5.3 Market size and forecast, by Application
  - 7.4.5.5.4 Market size and forecast, by End user
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Key market trends, growth factors and opportunities
  - 7.4.5.6.2 Market size and forecast, by Type
  - 7.4.5.6.3 Market size and forecast, by Application
  - 7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End user
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Key market trends, growth factors and opportunities
  - 7.5.5.1.2 Market size and forecast, by Type
  - 7.5.5.1.3 Market size and forecast, by Application
  - 7.5.5.1.4 Market size and forecast, by End user
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Key market trends, growth factors and opportunities
  - 7.5.5.2.2 Market size and forecast, by Type
  - 7.5.5.2.3 Market size and forecast, by Application
  - 7.5.5.2.4 Market size and forecast, by End user
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Key market trends, growth factors and opportunities
  - 7.5.5.3.2 Market size and forecast, by Type
  - 7.5.5.3.3 Market size and forecast, by Application
  - 7.5.5.3.4 Market size and forecast, by End user
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Key market trends, growth factors and opportunities
  - 7.5.5.4.2 Market size and forecast, by Type
  - 7.5.5.4.3 Market size and forecast, by Application
  - 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Ultravoice Limited
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Inhealth Technologies
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Griffin Labs
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Servona GmbH
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Labex Trade
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 AMPLICORD DI GABRIELLA SALVATORE
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Romet Limted
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Nu-Vois, LLC
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Atos Medical AB
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章電子喉頭（エレクトロラリンクス）市場：タイプ別

第5章電子喉頭（エレクトロラリンクス）市場：アプリケーション別

第6章電子喉頭（エレクトロラリンクス）市場：エンドユーザー別

第7章電子喉頭（エレクトロラリンクス）市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 電子喉頭（エレクトロラリンクス）市場：タイプ別

第5章 電子喉頭（エレクトロラリンクス）市場：アプリケーション別

第6章 電子喉頭（エレクトロラリンクス）市場：エンドユーザー別

第7章 電子喉頭（エレクトロラリンクス）市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章電子喉頭（エレクトロラリンクス）市場：タイプ別

第5章電子喉頭（エレクトロラリンクス）市場：アプリケーション別

第6章電子喉頭（エレクトロラリンクス）市場：エンドユーザー別

第7章電子喉頭（エレクトロラリンクス）市場：地域別

第8章企業情勢

第9章企業プロファイル